← Insider buys
TCRR

Tcr2 Therapeutics Inc.

President and CEO Garry E Menzel sold $35K of Tcr2 Therapeutics Inc.

Sold$35,034
$1.10Price
31,938Shares
−5%Stake

What TCRR did after the filing

Prices for TCRR after this filing aren't in yet.

Traded Fri, Dec 9. Filed Tue, Dec 13, 3:19 PM ET, during the session. Not investment advice.